Brazil has a booming pharmaceutical market. The pharmaceutical industry in Brazil is the sixth biggest in the world in terms of value. While generics does not have a leading market share in the industry as of yet, it is growing slowly. Prescription drugs account for nearly half of the market, while OTC drugs make up for 27% of the sector. Generics account for 23% as of present.
The generic industry in Brazil has been experiencing some decline in recent years, though it has managed to increase its market share. The market has seen fierce competition within domestic players and this has affected the overall value growth of the industry.
Analyzing Generics Market in Brazil 2017 - a comprehensive coverage of the Brazilian generic drugs market. Beginning with a sectional description on the global generic industry, the report looks at an overview of the industry, an analysis of the market volume and value, industry segmentation and an industry forecast.
The Generics Industry in Brazil is analyzed through an industry overview which spans the data from 2012 till 2021. An analysis of the industry's value and volume data is included along with an industry segmentation by geography. Industry forecast of the industry is also included.
Analysis of the major industry players in the Brazilian generics market are analyzed through an analysis of their business segments, a financial analysis and a SWOT analysis. Players analyzed include O Aché Laboratórios Farmacêuticos SA, Sanofi, Eurofarma Laboratórios Ltda and others. This concludes this comprehensive research report.
Key Topics Covered:
A. Executive Summary
B. Analyzing the Global Generics Industry
C. Generics Industry in Brazil
D. Generics Industry in Brazil: Porter's Five Forces Strategy Analysis
E. Major Industry Players
- Allergan Plc
- EMS Sigma Pharma
- Eurofarma Laboratórios Ltda
- Les Laboratoires Servier
- O Aché Laboratórios Farmacêuticos SA
- Sanofi SA
For more information about this report visit http://www.researchandmarkets.com/research/7fxhmn/analyzing